Effects of Extended Release Niacin added to Simvastatin/Ezetemibe on Glucose and Insulin values in AIM HIGH

BACKGROUND: Niacin is an anti-dyslipidemic agent that may cause blood sugar elevation in patients with diabetes, but its effects on glucose and insulin values in non-diabetic statin-treated subjects with cardiovascular disease and at high risk for diabetes are less well known. METHODS: This was a pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Med
Main Authors: Goldberg, Ronald B., Bittner, Vera A., Dunbar, Richard L., Fleg, Jerome L., Grunberger, George, Guyton, John R., Leiter, Lawrence A., McBride, Ruth, Robinson, Jennifer G., Simmons, Debra L., Wysham, Carol, Xu, Ping, Boden, William E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914402/
https://ncbi.nlm.nih.gov/pubmed/27036394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2016.02.039
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados